FDA Brief

Warning letters Animal

FDA warning letter to

Plantacea, LLC dba Kahm

High riskIssued May 26, 2022Posted May 26, 2022Center for Veterinary Medicine

FDA warned Plantacea, doing business as Kahm, about unapproved CBD drugs for humans and animals and adulterated CBD gummies.

What happened

FDA reviewed kahmcbd.com and linked social media in May 2022 and found order-taking and claims for CBD products for humans and animals. FDA said the animal products were unapproved new animal drugs and the human products were unapproved new drugs and misbranded. FDA also said two CBD Gummies flavors were adulterated because they contain an unsafe food additive.

What FDA found

  1. CBD Hemp Pellets and K9 Soft Chews were marketed as unapproved new animal drugs and are unsafe and adulterated.

    FD&C Act §§ 512(a), 501(a)(5); 21 U.S.C. §§ 360b(a), 351(a)(5)
  2. Kahm CBD products for humans and Tanka products for humans were marketed as unapproved new drugs without an approved application.

    FD&C Act §§ 505(a), 301(d); 21 U.S.C. §§ 355(a), 331(d)
  3. Kahm CBD products for humans and Tanka products for humans were misbranded because their labeling lacked adequate directions for use.

    FD&C Act § 502(f)(1); 21 U.S.C. § 352(f)(1)
  4. CBD Gummies in Blue Raspberry and Raspberry flavors were adulterated because they contain CBD, an unsafe food additive.

    FD&C Act §§ 402(a)(2)(C)(i), 301(ll); 21 U.S.C. §§ 342(a)(2)(C)(i), 331(ll)
  5. CBD Hemp Pellets were labeled for horses and livestock, raising concerns about CBD residues in human food from food-producing animals.

    FD&C Act §§ 301(ll), 402(a)(2)(C)(i); 21 U.S.C. §§ 331(ll), 342(a)(2)(C)(i)
  6. CBD Broad Spectrum Hemp Extract and Tanka bands were promoted as dietary supplements, but FDA says CBD is excluded and the bands are not intended for ingestion.

    FD&C Act §§ 201(ff)(3)(B)(i)-(ii), 201(ff)(2)(A)(i); 21 U.S.C. § 321(ff)(3)(B)(i)-(ii), 321(ff)(2)(A)(i)

What FDA wants

FDA asks the company to take immediate action to stop selling any unapproved CBD products for food-producing animals. The provided letter does not show a response deadline.

Who should pay attention

  • CBD and hemp product brands
  • retailers selling CBD foods, supplements, or topicals
  • makers of horse or livestock supplements

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  2. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  3. House of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog

    FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.

    High risk
  4. Holista LLC dba HolistaPet

    FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.

    High risk